Cargando…

Targeting gene fusions in non-small cell lung cancer—a ceaseless success story?

Detalles Bibliográficos
Autor principal:	Hydbring, Per
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413033/ https://www.ncbi.nlm.nih.gov/pubmed/37577325 http://dx.doi.org/10.21037/tlcr-23-284

Ejemplares similares

The ceaseless wind : an introduction to the theory of atmospheric motion /
por: Dutton, John A. (John Altnow)
Publicado: (2002)

The ceaseless wind : an introduction to the theory of atmospheric motion /
por: Dutton, John A. (John Altnow)
Publicado: (1976)

Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients
por: Hydbring, Per
Publicado: (2023)

Ceaseless Experimentation Sparks Fireworks, Art, and Science
por: Breedlove, Byron
Publicado: (2015)

Complex glandular pattern as an independent predictor of survival probability in lung adenocarcinoma
por: Hydbring, Per
Publicado: (2022)

The Success Story Continues …
por: Scheffler, Ulf, et al.
Publicado: (2017)

Acquired BRAF gene fusions in Osimertinib resistant EGFR-mutant non-small cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

Identifying successful biomarkers for patients with non-small-cell lung cancer
por: Friedlaender, Alex, et al.
Publicado: (2019)

Success Story of IAPCON – 2021
por: Bhadani, Umesh
Publicado: (2021)

Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?
por: Spagnolo, Calogera Claudia, et al.
Publicado: (2023)

Immunotherapy as a targeted therapy in non-small cell lung cancer
por: Rocco, Danilo, et al.
Publicado: (2019)

Dermoscopy in the Southern Hemisphere: a success story
por: Soyer, H. Peter
Publicado: (2012)

Implications of the success of EGFR-targeted therapy in advanced non–small cell lung cancer for its application to the adjuvant setting
por: Takeda, Masayuki
Publicado: (2020)

Asbestos conceives Fe(II)-dependent mutagenic stromal milieu through ceaseless macrophage ferroptosis and β-catenin induction in mesothelium
por: Ito, Fumiya, et al.
Publicado: (2020)

Precision medicine in early breast cancer—beginning of a successful story?
por: Eniu, A., et al.
Publicado: (2023)

Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohort
por: Wang, Qing, et al.
Publicado: (2022)

Catheter ablation of supraventricular tachycardias—a success story
por: Althoff, Till F, et al.
Publicado: (2022)

Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going?
por: Passiglia, Francesco, et al.
Publicado: (2020)

RET Fusion Genes in Korean Non-Small Cell Lung Cancer
por: Yoo, Seung Soo, et al.
Publicado: (2013)

Targeted therapy of RET fusion-positive non-small cell lung cancer
por: Shen, Zixiong, et al.
Publicado: (2022)

Science for service in a society is the success story of scientists with serenity
por: Kangueane, Pandjassarame, et al.
Publicado: (2020)

Molecular Pathology, Diagnostics and Therapeutics: A Story of Success in 2022
por: Bustin, Stephen A.
Publicado: (2023)

Smoking control in Brazil: a public health success story
por: Lotufo, Paulo Andrade
Publicado: (2017)

Immune checkpoint inhibitors for patients with gene-rearranged non-small cell lung cancer
por: Uehara, Yuji, et al.
Publicado: (2022)

The Fusion Gene Landscape in Taiwanese Patients with Non-Small Cell Lung Cancer
por: Chang, Ya-Sian, et al.
Publicado: (2021)

EML4-ALK fusion gene in non-small cell lung cancer
por: Lei, Yu, et al.
Publicado: (2022)

Importance of ROS1 gene fusions in non-small cell lung cancer
por: Muminovic, Meri, et al.
Publicado: (2023)

Postoperative radiotherapy in resected non-small cell lung cancer: The never-ending story
por: Serrano, Javier, et al.
Publicado: (2021)

Journal of Laboratory Physicians (JLP): Success Story Despite Many Challenges
por: Singh, Sarman
Publicado: (2011)

Oncogene alterations in non-small cell lung cancer—have we MET a new target?
por: Dempke, Wolfram C. M., et al.
Publicado: (2022)

Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature
por: Tsakonas, Georgios, et al.
Publicado: (2022)

Evolution in the management of non-small cell lung cancer in Brazil
por: Fernandes, Caio Júlio Cesar dos Santos
Publicado: (2017)

Realities of KRAS-mutated non-small cell lung cancer
por: Min, Young Joo
Publicado: (2017)

Immunotherapy in non-small cell lung cancer: advancements and challenges
por: Zhou, Fei, et al.
Publicado: (2021)

Resectable non-small cell lung cancer: an evolving landscape
por: Loh, Jerold, et al.
Publicado: (2022)

EML4-ALK Fusion Gene in Korean Non-Small Cell Lung Cancer
por: Jin, Guang, et al.
Publicado: (2012)

Plastics: From a Success Story to an Environmental Problem and a Global Challenge
por: Dris, Rachid, et al.
Publicado: (2020)

BRAF Mutations and Resistance of Non-Small Cell Lung Cancer to BRAF-Targeted Therapies Using Liquid Biopsy
por: Li, Ming, et al.
Publicado: (2021)

Discovery Stories of RET Fusions in Lung Cancer: A Mini-Review
por: Takeuchi, Kengo
Publicado: (2019)

The not so small role of adjuvant chemotherapy in resected non-small cell lung cancer
por: Almquist, Daniel R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eqee7mc3k0tajqd9gaie6fgrsa